RT Book, Section A1 Gasper, Warren J. A1 Iannuzzi, James C. A1 Johnson, Meshell D. A2 Papadakis, Maxine A. A2 McPhee, Stephen J. A2 Rabow, Michael W. A2 McQuaid, Kenneth R. SR Print(0) ID 1193148830 T1 Occlusive Disease: Femoral & Popliteal Arteries T2 Current Medical Diagnosis & Treatment 2023 YR 2023 FD 2023 PB McGraw-Hill Education PP New York, NY SN 9781264687343 LK accessmedicine.mhmedical.com/content.aspx?aid=1193148830 RD 2024/03/29 AB Key Clinical Updates in Occlusive Disease: Femoral & Popliteal ArteriesDual treatment with rivaroxaban 2.5 mg orally twice daily and aspirin 81 mg orally daily has been shown to reduce limb-related events, major amputation, and cardiovascular events.Bauersachs RM et al. J Am Coll Cardiol. [PMID: 34010631]